本页面由Tiger Trade Technology Pte. Ltd.提供服务

Reata制药

172.36
0.0000
成交量:- -
成交额:- -
市值:65.66亿
市盈率:-57.69
高:172.36
开:172.36
低:172.36
收:172.36
52周最高:172.36
52周最低:172.36
股本:3,809.73万
流通股本:2,974.88万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.9879
每股收益(LYR):-8.5410
净资产收益率:-112.39%
总资产收益率:-37.66%
市净率:75.22
市盈率(LYR):-20.18

数据加载中...

2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities